论文部分内容阅读
目的探讨相关药物治疗高危孕妇产后出血的临床疗效。方法选取高危剖宫产及有产后出血因素的孕妇60例,随机分为3组。A组孕妇分娩后在正常缩宫素的基础上采用舌下含服米索前列醇片进行治疗;B组孕妇分娩后在正常缩宫素的基础上注射卡前列素氨丁三醇注射液250μg,C组孕妇分娩后在正常缩宫素的基础上加用缩宫素。比较3组患者的治疗效果。结果 A组与B组孕妇的产后出血率均小于C组,差异有统计学意义(P<0.05)。结论米索前列醇片与卡前列素氨丁三醇注射液用于孕妇产后出血疗效较佳,安全有效。
Objective To investigate the clinical efficacy of related drugs in treating high-risk pregnant women postpartum hemorrhage. Methods Sixty pregnant women at high risk of cesarean section and postpartum hemorrhage were randomly divided into three groups. A group of pregnant women after childbirth in the normal oxytocin on the basis of sublingual misoprostol tablets for treatment; B group of pregnant women after delivery in the normal oxytocin on the basis of carboprost trometamol injection 250μg , C group of pregnant women after delivery in the normal oxytocin based on the use of oxytocin. Compare the treatment effect of 3 groups of patients. Results The postpartum hemorrhage rates of pregnant women in group A and group B were less than those in group C, the difference was statistically significant (P <0.05). Conclusion Misoprostol and carboprost trometamol injection for postpartum hemorrhage in pregnant women better efficacy, safe and effective.